The Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Competitive Bidding Program (CBP) was mandated by Congress through the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA). This legislation was largely a response to multiple cases of profiteering by unsavory DME companies in various areas of the US. As you can imagine, there was considerable anxiety for DME business owners across the country. A competitive bid process for guardrails on the highway is one thing, but to thrust healthcare services into a competitive bid program would seal the fate of most smaller providers. Not to mention the outcomes for the end users, the patients.